Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Feb 2009

Oguzulgen I Kivilcim, Yilmaz E, Demirtas Senay, Erkekol Ferda Oner, Ekim Numan, Demir Nalan, Numanoglu Numan, Ozel Duygu, Ulu Arzu, Akar Nejat

Abstract excerpt

Polymorphism in plasminogen activator inhibitor-1 gene is suggested to be associated with an increased risk of venous thromboembolism. The aim of this study was to investigate the association of plasminogen activator inhibitor-1 gene polymorphism and its coexistence with factor-V-Leiden and prothrombin-20210 mutations in pulmonary thromboembolism. The authors investigated plasminogen activator inhibitor-1 4G/5G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Factor V

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Plasminogen Activator Inhibitor 1

Share to Prothrombin

Share to Pulmonary Embolism

Share to Recurrence

Share to Risk Assessment

Source

Identifiers

PMID: 18160588
DOI: 10.1177/1076029607305110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.PMID 18160588Read ↗

The prothrombin gene variant 20210A in venous and arterial thromboembolism.Semantic proximity Read ↗

The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis.Semantic proximity Read ↗

The prothrombin gene G20210A variant in an unselected thromboembolic population. A Belgian prospective clinical study.Semantic proximity Read ↗

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.Semantic proximity Read ↗

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Semantic proximity Read ↗

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.Semantic proximity Read ↗

Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.Semantic proximity Read ↗

[20210A mutation of the prothrombin and venous thromboembolism gene].Semantic proximity Read ↗

The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.Semantic proximity Read ↗

Prothrombin gene 20210A mutation in Slovak population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.